ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "immunosuppressants"

  • Abstract Number: 119 • 2020 Pediatric Rheumatology Symposium

    Actual Medication Usage of Patients with Juvenile Onset Systemic Lupus Erythematosus Using Japanese Health Insurance Database

    Takayuki Kishi1, Takako Miyamae 2, Ryoko Sakai 3, Yumi Tani 2, Satoru Nagata 1 and Masayoshi Harigai 3, 1Department of Pediatrics, Tokyo Women's Medical University, Tokyo, Japan, 2Pediatric Rheumatology, Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, 3Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan

    Background/Purpose: Background: Immunosuppressive therapy is the mainstay of treatment of child systemic lupus erythematosus (cSLE). However until very recently, the treatment of cSLE lacked uniformity.…
  • Abstract Number: 1198 • 2019 ACR/ARP Annual Meeting

    Practice Based Education Program to Increase Vaccination Rate in Patients on Immunotherapeutic Agents

    Andrea Soliman1, Soorya Aggarwal 1, Kyle Kreitman 1, Kourtney Erickson 1, Abdul Aleem 1 and Marie O'Brien 1, 1Lehigh Valley Health Network, Allentown, PA

    Background/Purpose: Immunosuppressive agents have changed the course of debilitating autoimmune conditions. Despite their advantages, these agents come with risk of vaccine preventable infections.1 Multiple organizations recommend…
  • Abstract Number: 2124 • 2019 ACR/ARP Annual Meeting

    Screening and Follow-up of Patients with Rheumatic Diseases and Rheumatological Treatments Infected with Trypanosoma Cruzi (American Trypanosomiasis or Chagas’ Disease). Is It Possible a Reactivation?

    Ariana Ringer1, Juan Pablo Ruffino 2, Nadia Cuadranti 2, Ignacio Rolla 2, Juan Manuel Vandale 2, Carla Achilli 2, Cecilia Argento 2, Florencia Martinez 2, Noel Cortese 2, Mariano Palatnik 2, Mariana Lagrutta 3, Rodolfo Leiva 4, Damian Aguila 5, Maria Jose Svetaz 6, Laura Cordoba 7, Milagros Zafra 8, Telma Gambander 8, Patricia Sciarrata 6, Silvina Villar 9, Florencia Gonzalez 9, Florencia Pacini 9, Ana Rosa Perez 9, Oscar Bottasso 9 and Marcelo Abdala 2, 1Rheumatology. Hospital Provincial del Centenario. Universidad Nacional de Rosario, Totoras, Santa Fe, Argentina, 2Rheumatology. Hospital Provincial del Centenario. Universidad Nacional de Rosario, Rosario, 3Internal Medicine. Hospital Provincial del Centenario. Universidad Nacional de Rosario, Rosario, 4Cardiology. Hospital Provincial del Centenario. Universidad Nacional de Rosario, Rosario, 5Infectology. Hospital Provincial del Centenario. Universidad Nacional de Rosario, Rosario, 6Central Laboratory. UNR, Rosario, 7Microbiology, Rosario, 8Microbiology. UNR, Rosario, 9Immunology. IDICER, CONICET, UNR, Rosario

    Background/Purpose: American Trypanosomiasis or Chagas Disease (CD) is a zoonotic infection, endemic in Latin America. It is a major cause of morbidity, mortality and economic…
  • Abstract Number: 2135 • 2019 ACR/ARP Annual Meeting

    Therapeutic Strategies and Survival in Patients with Interstitial Pneumonia with Autoimmune Features

    Marco Sebastiani1, Giulia Cassone 2, Caterina Vacchi 1, Lisa De Pasquale 1, Stefania Cerri 3, Giovanni Della Casa 4, Carlo Salvarani 1 and Andreina Manfredi 1, 1Rheumatology Unit, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria Policlinico di Modena, MOdena, Emilia-Romagna, Italy, 2Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Emilia-Romagna, Italy, 3Respiratory Disease Unit, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena, Emilia-Romagna, Italy, 4Radiology Unit, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena, Emilia-Romagna, Italy

    Background/Purpose: Recently the term “interstitial pneumonia with autoimmune features” (IPAF) has been proposed to identify patients with interstitial lung disease and autoimmune characteristics, not fulfilling…
  • Abstract Number: 2782 • 2019 ACR/ARP Annual Meeting

    Comparative Risks of Cardiovascular Disease Among SLE Patients Receiving Immunosuppressive Medications

    Daniel Li1, Candace Feldman 1, Hongshu Guan 1, Brendan Everett 2, Seoyoung C. Kim 3 and Karen Costenbader 2, 1Brigham and Women's Hospital, Boston, 2Brigham and Women's Hospital, Boston, MA, 3Brigham and Women’s Hospital and Harvard Medical School, Boston

    Background/Purpose: Human studies examining cardiovascular disease (CVD) risk associated with immunosuppressants (IS) have been limited, but mycophenolate mofetil (MMF) was shown to suppress vascular smooth muscle…
  • Abstract Number: 705 • 2018 ACR/ARHP Annual Meeting

    Prevalence of Cervical Human Papillomavirus Infection in Women with Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis

    Claudia Mendoza Pinto1,2, Nicolás Molano-González3, Adriana Rojas-Villarraga4, Verónica Vallejo-Ruiz5, Socorro Méndez-Martínez6 and Mario García-Carrasco1,7, 1Systemic Autoimmune Diseases Research Unit,, UMAE, HE CMN Manuel Ávila Camacho-CIBIOR, Instituto Mexicano del Seguro Social, Puebla, Mexico, 2Departament of Research, Facultad de Medicina, Benemerita Universidad Autonoma de Puebla, Puebla, Mexico, 3Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia, 4Instituto de Investigaciones de la Fundación Universitaria de Ciencias de la Salud (FUCS), Bogotá, Colombia, 5Virology Laboratory, Centro de Investigación Biomédica de Oriente, Instituto Mexicano del Seguro Social, Metepec, Puebla, Mexico, 6Research in Health Coordination,, Delegation of Puebla, Instituto Mexicano del Seguro Social, Puebla, Mexico, 7Inmunología y Reumatología, Universidad Autónoma de Puebla, Puebla, Mexico

    Background/Purpose: Human papillomavirus (HPV), a common sexually-transmitted infection, is considered a necessary cause of cervical cancer. The objectives of this systematic review and meta-regression were:…
  • Abstract Number: 1234 • 2018 ACR/ARHP Annual Meeting

    Incidence of Conversion of Screening Tests for M. Tuberculosis (PPD, GIF-release assay) in a Metropolitan Cohort of Patients Treated with TNF-α Inhibitors

    Hung Trinh and Darren Tabechian, Medicine, Division of Allergy, Immunology and Rheumatology, University of Rochester Medical Center, Rochester, NY

    Background/Purpose: Tumor necrosis factor alpha (TNF-α) inhibitors are used to reduce the inflammatory process in many autoimmune diseases. Due to the risk of reactivation of…
  • Abstract Number: 1249 • 2018 ACR/ARHP Annual Meeting

    Contraception Compliance in Patients with Rheumatological Diseases on Disease Modifying Antirheumatic and Cytotoxic Drugs

    Sara Naji Rad1, Paris Pacheco2, Luis Calvo2, Htet Htet Maung2, Wajiha Illyas2 and Prachi Anand3, 1Internal Medicine, Nassau University Medical Center, East meadow, NY, 2Internal Medicine, Nassau University Medical Center, East Meadow, NY, 3Chief of Rheumatology, Nassau University Medical Center, East Meadow, NY

    Background/Purpose: Women of child bearing age with autoimmune diseases are often prescribed teratogenic medications as Methotrexate, Mycophenolate Mofetil, Leflunomide and Cyclophosphamide. Contraceptive compliance in this…
  • Abstract Number: 1289 • 2018 ACR/ARHP Annual Meeting

    Immunosuppressant Use and Gout in the Prevalent Solid Organ Transplant Population

    Andrew Milgroom1, Mara Onita Lenco1, Kevin Francis1, Jeffrey D. Kent2, Brian LaMoreaux3 and Brian F. Mandell4, 1Trinity Partners, Waltham, MA, 2Medical Affairs, Horizon Pharma USA, Inc, Lake Forest, IL, 3Horizon Pharma USA, Inc, Lake Forest, IL, 4Rheumatology, Cleveland Clinic, Cleveland, OH

    Background/Purpose: Gout is a frequent co-morbidity of solid organ transplant (SOT). Cyclosporine (CsA) is often cited as the main cause of gout in SOT, as…
  • Abstract Number: 1768 • 2018 ACR/ARHP Annual Meeting

    Kidney Involvement, Poor Performance Status, and Higher Cumulative Dose of Glucocorticoid Are the Risk Factors of the Discontinuation of Immunosuppressant in Patients with Antineutrophil Cytoplasmic Antibody Associated Vasculitis

    Takamasa Murosaki, Takeo Sato, Katsuya Nagatani and Seiji Minota, Department of Internal Medicine, Division of Rheumatology/Clinical Immunology, Jichi Medical University, Shimotsuke, Japan

    Background/Purpose: The use of immunosuppressant (IS) with glucocorticoid is recommended as remission induction treatment for severe cases with antineutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV).…
  • Abstract Number: 1877 • 2018 ACR/ARHP Annual Meeting

    Specific Pneumoproteins Predict Progression of Interstitial Lung Disease in Systemic Sclerosis Patients Undergoing Treatment with Immunosuppression

    Elizabeth R. Volkmann1, Donald P. Tashkin1, Masataka Kuwana2, Ning Li3, Julio Charles4, Faye N. Hant5, Galina S. Bogatkevich6, Tanjina Akter6, Michael Roth7, Hyun J. Grace Kim8, Jonathan Goldin9, Dinesh Khanna10, Philip J. Clements11, Daniel E. Furst7, Robert Elashoff12, Rick Silver13 and Shervin Assassi14, 1University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA, 2Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan, 3Biomathematics, University of California, Los Angeles, Los Angeles, CA, 4University of Texas Health Science Center at Houston, Houston, TX, 5Rheumatology, Medical University of South Carolina, Charleston, SC, 6Division of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, Charleston, SC, 7Medicine, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA, 8Department of Radiology, David Geffen School of Medicine at UCLA, Los Angeles, CA, 9Department of Radiological Sciences at UCLA, University of California, Los Angeles, David Geffen School of Medicine, Santa Monica, CA, 10Division of Rheumatology, Department of Internal Medicine, University of Michigan Scleroderma Program, University of Michigan, Ann Arbor, MI, 11Medicine, University of California, Los Angeles, Los Angeles, CA, 12University of California, Los Angeles, Los Angeles, CA, 13Rheumatology, Medical University of SC, Charleston, SC, 14University of Texas McGovern Medical School, Houston, TX

    Background/Purpose: Interstitial lung disease (ILD) is the leading cause of death in systemic sclerosis (SSc). While some SSc-ILD patients are stable or improve with immunosuppressive…
  • Abstract Number: 1878 • 2018 ACR/ARHP Annual Meeting

    Immunosuppression in Diffuse Systemic Sclerosis Improves Outcomes Using a Novel Composite Response Index

    Boyang Zheng1, Mianbo Wang2 and Murray Baron3, 1Rheumatology, McGill University Health Center (MUHC), Montreal, QC, Canada, 2Lady Davis Institute for Medical Research, Montreal, QC, Canada, 3Rheumatology, McGill University, Jewish General Hospital, Montreal, QC, Canada

    Background/Purpose: Diffuse systemic sclerosis (dcSSc) is a devastating multi-organ disease where the mainstay of treatment is immunosuppression. Data on these therapies are mostly based on…
  • Abstract Number: 2269 • 2018 ACR/ARHP Annual Meeting

    Infliximab Therapy in Refractory Retinal Vasculitis of Behçet’s Disease, Short and Long-Term Follow-up. Multicenter Study of 72 Patients

    José Luis Martín-Varillas1, Belén Atienza-Mateo1, Vanesa Calvo-Río2, Diana Prieto Peña2, Monica Calderón Goercke2, Rosalía Demetrio-Pablo3, Javier Loricera3, M. Victoria Hernández4, Alfredo Adan5, Marina Mesquida5, Diana Peiteado6, David Diaz-Valle7, Lucía Martínez-Costa8, Elia Valls-Pascual8, Miguel A. Caracuel9, Angel Garcia-Aparicio10, Jose M Herreras11, Miguel Cordero-Coma12, Carlos Alberto Montilla-Morales13, Alejandro Fonollosa14, Antonio Atanes15, Félix Francisco16, Ignacio Torre-Salaberri17, Olga Maíz18, Ana Blanco19, Cruz Fernandez-Espartero20, Norberto Ortego Centeno21, Enrique Raya Álvarez22, Myriam Gandía23, Francisco Javier López Longo24, Maria Alcalde-Villar25, Cristina Fernández-Carballido26, Esperanza Pato Cour27, Oscar Ruiz Moreno28, Fernando Jiménez-Zorzo29, Raquel Almodóvar González30, Carmen Carrasco-Cubero31, Luis Francisco Linares32, Fredeswinda I. Romero-Bueno33, Santos Insua34, Senen González-Suárez35, Marisa Hernández36, Emma Beltrán37, Juan Cruz38, Carlos Férnandez Cid39, Elena Aurrecoechea40, Enar Pons1, Miguel Angel González-Gay3 and Ricardo Blanco1, 1Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, 2Rheumatology, Rheumatology. Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, 3Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, 4Rheumatology, Hospital Clinic. Barcelona. Spain, Barcelona, Spain, 5Hospital Clinic. Barcelona. Spain, Barcelona, Spain, 6Rheumatology, Rheumatology, La Paz University Hospital, Madrid, Spain, 7Hospital Clínico San Carlos. Madrid. Spain, Madrid, Spain, 8Hospital Universitario Doctor Peset. Valencia. Spain, Valencia, Spain, 9Hospital de Córdoba, Córdoba, Spain., Córdoba, Spain, 10Rheumatology, Hospital de Toledo. Toledo. Spain, Toledo, Spain, 11Ophthalmology, Hospital Universitario, IOBA. Valladolid. Spain, Valladolid, Spain, 12Ophthalmology, Hospital de León. Spain, León, Spain, 13Hospital Clínico Universitario de Salamanca. Spain, Salamanca, Spain, 14Ophthalmology, Hospital de Cruces. Bilbao. Spain, Bilbao, Spain, 15Complejo Hospitalario Universitario A Coruña. Spain, A Coruna, Spain, 16Rheumatology, Hospital Doctor Negrín. Las Palmas de Gran Canaria. Spain, Las Palmas de Gran Canaria, Spain, 17Rheumatology, Hospital Universitario de Basurto. Bilbao. Spain, Bilbao, Spain, 18Hospital Universitario Donostia. San Sebastian. Spain, San Sebastián, Spain, 19Ophtamology, Hospital Universitario Donostia. San Sebastian. Spain, San Sebastian, Spain, 20Rheumatology, Hospital de Móstoles. Madrid. Spain, Madrid, Spain, 21Medicine Department, Hospital Universitario San Cecilio. Granada. Spain, Granada, Spain, 22Rheumatology, Hospital Universitario San Cecilio. Granada. Spain, Granada, Spain, 23Rheumatology, Hospital Puerta del Mar. Cádiz. Spain, Cádiz, Spain, 24Rheumatology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain, 25Hospital Severo Ochoa, Madrid, Spain, Madrid, Spain, 26Rheumatology Division, Hospital General Universitario de Elda, Elda, Spain, 27Rheumatology, Hospital Clínico San Carlos, Madrid, Spain, 28Ophthalmology and Rheumatology, Hospital Miguel Servet. Zaragoza. Spain, Zaragoza, Spain, 29Hospital Miguel Servet. Zaragoza. Spain, Zaragoza, Spain, 30Rheumatology, Hospital Universitario Fundación Alcorcón. Madrid. Spain, Madrid, Spain, 31Hospital de Mérida. Spain, Mérida, Spain, 32Rheumatology, Hospital Virgen de la Arrixaca. Murcia. Spain, Murcia, Spain, 33Section for Autoimmune Diseases, Rheumatology, Fundación Jiménez Díaz University Hospital & Health Research Institute, Madrid, Spain, 34Rheumatology, Hospital Universitario Santiago de Compostela. La Coruña. Spain, La Coruña, Spain, 35Rheumatology, Hospital de Cabueñes. Gijón. Spain, Gijón, Spain, 36Ophthalmology, Hospital General Universitario de Valencia. Spain, Valencia, Spain, 37Rheumatology, Hospital del Mar. Barcelona. Spain, Barcelona, Spain, 38Hospital de Pontevedra. Pontevedra. Spain, Pontevedra, Spain, 39Ophthalmology, Hospital de Pontevedra. Pontevedra. Spain, Pontevedra, Spain, 40Rheumatology, Hospital de Sierrallana, Torrelavega. Cantabria. Spain, Torrelavega, Spain

    Background/Purpose: Retinal vasculitis is a serious complication of uveitis due to Behçet’s disease (BD). The treatment is based on corticosteroids, conventional immunosuppressants (IS) and anti-TNF-α…
  • Abstract Number: 2669 • 2018 ACR/ARHP Annual Meeting

    Assessing the Need for Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis in SLE Patients on Immunosuppression

    Kimberly A. Lynch1, Maria Salgado Guerrero2, Alejandra Londono Jimenez1, Inessa Gendlina3, Wenzhu B. Mowrey4, Michele H. Mokrzycki5 and Anna R. Broder6, 1Internal Medicine, Montefiore Medical Center, Bronx, NY, 2Internal Medicine, Jacobi Medical Center, Bronx, NY, 3Infectious Disease, Albert Einstein College of Medicine, Bronx, NY, 4Albert Einstein College of Medicine, Bronx, NY, 5Nephrology, Montefiore Medical Center, Bronx, NY, 6Rheumatology, Montefiore Medical Center, Bronx, NY

    Background/Purpose: The risk-benefit of Pneumocystis jiroveci pneumonia (PCP) prophylaxis in systemic lupus erythematosus (SLE) is not well defined and there are no SLE-specific guidelines. On…
  • Abstract Number: 2713 • 2018 ACR/ARHP Annual Meeting

    Is Effectiveness of Immunosuppression for Interstitial Lung Disease in Systemic Sclerosis (SSc) Modified By Lung Disease Severity or SSc Duration?

    Sabrina Hoa1, Sasha Bernatsky2, Russell Steele3 and Marie Hudson1, 1Jewish General Hospital, Lady Davis Institute and McGill University, Montreal, QC, Canada, 2Divisions of Rheumatology and Clinical Epidemiology, The Research Institute of the McGill University Health Centre, Montreal, QC, Canada, 3Department of Mathematics and Statistics, McGill University, Montreal, QC, Canada

    Background/Purpose: Interstitial lung disease (ILD) is a leading cause of mortality in SSc. Immunosuppression is used to treat ILD, but little is known about its…
  • 1
  • 2
  • 3
  • 4
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.